Three stocks to profit from “Trumpcare”

This is an interesting time for the US healthcare industry, says professional investor Paul Major, which offers a great opportunity for long-term investors.

Each week, a professional investor tells us where he'd put his money.This week:Paul Major of the BB Healthcare Trust.

Three topics currently dominate our thoughts because they could profoundly affect the healthcare industry. These are the proposal to "repeal and replace" the Affordable Care Act (ACA, or Obamacare) in the US, the reality of Donald Trump's promise to tackle "high" drug prices, and the question of what shape his long-awaited tax plan will take (for example, whether he might slash corporation tax from 35% to 15%).

Drug pricing has been a hot topic for several years. Thus far, any attempt at direct government action has floundered. The past three administrations have looked at this topic, and found little support from Congress for government to play a more direct role. While President Trump may Tweet that he is "working on a new system where pricing for the American people will come way down!", the legal pathway to facilitate this remains unclear. He has also recognised that innovation needs to be rewarded. So we are at a point where the share prices of many drug firms are pricing in what we consider a worst-case scenario.

With the details of US healthcare reform still largely uncertain, and valuations relative to the wider market depressed relative to history, this is an interesting time for the industry and a great opportunity for long-term investors.

Our investment strategy is unchanged: high-conviction, unconstrained, long-only positions with a maximum of 35 stocks. However, when we decide how to weight our portfolio, we believe that a balance that skews toward those firms that could benefit from reforms is preferable. Each of the following stocks have merit in their own right under the status quo, but their options for benefiting from these changes could prove very valuable.

On 6 March the Republicans unveiled their long-awaited replacement for Obamacare. Unsurprisingly, this met with mixed reactions. For health insurers such as Anthem (NYSE: ANTM) the new legislation is positive. It both reverses the taxes that Obamacare imposed on them and puts insurers at the forefront of plans for individual coverage.

Retailer Walgreens Boots Alliance (Nasdaq: WBA) is largely protected from Trump's healthcare reforms. The company has been refreshing the Walgreens brand in the US, focusing on higher margin cosmetic products, and using its pharmacy operations to drive footfall into stores. Pricing for drugs may change, but demand will only rise. Healthcare remains an attractive long-term growth story as the population ages.

Wholesaler AmerisourceBergen (NYSE: ABC) should be a significant winner from any sort of tax reform. Compared with its peers, ABC looks best positioned for a transition to a fee-per-service model rather than the current situation where distributors have relied on drug price increases to bolster profits.

Recommended

Six high-yielding funds for income investors to buy now
Share tips

Six high-yielding funds for income investors to buy now

Rising interest rates are starting to make many popular income funds look less than attractive. Here, David Stevenson picks six that should weather th…
24 May 2022
Amazon’s shares have fallen hard – value investors should take note
Share tips

Amazon’s shares have fallen hard – value investors should take note

Investors have dumped Amazon shares as post-pandemic life returns to normal. But it still has plenty of competitive advantages, says Russell Hargreave…
23 May 2022
Three high-yielding FTSE 250 dividend stocks I’d invest in right now
Share tips

Three high-yielding FTSE 250 dividend stocks I’d invest in right now

The average FTSE 250 dividend yield is around 2.4%, but many stocks yield much more. Rupert Hargreaves picks the best FTSE 250 stocks for income inves…
23 May 2022
JD Sports will get back on track – here's how to play it
Trading

JD Sports will get back on track – here's how to play it

Sportswear retailer JD Sports was a profitable trade in 2019 and is worth watching again, says Matthew Partridge.
23 May 2022

Most Popular

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022